...
首页> 外文期刊>Journal of strength and conditioning research >Acute cardiovascular response in anabolic androgenic steroid users performing maximal treadmill exercise testing.
【24h】

Acute cardiovascular response in anabolic androgenic steroid users performing maximal treadmill exercise testing.

机译:进行最大程度的跑步机运动测试的合成代谢雄激素类固醇使用者的急性心血管反应。

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to investigate the cardiovascular effects of anabolic androgenic steroid (AAS) use, specifically the hemodynamic response, during maximal treadmill exercise testing by comparing the exercise response between users of AAS (U-AAS) and non-AAS users (N-AAS). Twenty-four men (n=12; 29+/-3.4 years and n=12; 29.5+/-8.2 years for the U-AAS and N-AAS groups, respectively) with regular participation in both resistance (mean=6 d.wk) and aerobic exercise (mean=2 d.wk) volunteered for the study. Both groups of subjects completed a ramp-protocol maximal treadmill exercise test to volitional fatigue. Several hemodynamic and metabolic measures were obtained before, during, and after testing. The results demonstrate for the first time that chronic administration of high doses of AAS (355.4+/-59.47 mg.wk) lead to hemodynamic and metabolic response impairment. In conclusion, the chronotropic significant incompetence in the current study was reflected by an exaggerated hemodynamic response to exercise. Furthermore, the findings suggest that nonusers of AAS showed increases in VO2max when compared to the AAS group. Therefore, this study provides a contraindication to AAS use, especially in those at increased risk of cardiovascular events.
机译:这项研究的目的是通过比较AAS(U-AAS)和非AAS使用者之间的运动反应来研究最大剂量跑步机运动测试期间使用同化雄激素类固醇(AAS)对心血管的影响,尤其是血液动力学反应。 N-AAS)。二十四名男性(分别为U-AAS和N-AAS组的n = 12; 29 +/- 3.4岁和n = 12; n = 12; 29.5 +/- 8.2岁),两个参与者都定期参加抵抗运动(平均= 6 d .wk)和有氧运动(平均= 2 d.wk)自愿参加了这项研究。两组受试者均完成了针对疲劳的斜坡协议最大跑步机运动测试。在测试之前,之中和之后都获得了几种血液动力学和代谢指标。结果首次证明了长期服用高剂量的AAS(355.4 +/- 59.47 mg.wk)会导致血液动力学和代谢反应受损。总而言之,当前研究中变时性显着的无能通过运动对血液动力学的过度反应来反映。此外,研究结果表明,与AAS组相比,不使用AAS的人最大摄氧量增加。因此,本研究为AAS的使用提供了禁忌症,尤其是在那些心血管事件风险增加的人群中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号